Lynne Chou joined Kleiner Perkins Caufield and Byers in 2013 and focuses on life science investing in medical devices, diagnostics, and digital health. She works alongside entrepreneurs to develop impactful technologies and therapies for improving patients’ lives.

Before joining KPCB, Lynne had over 12 years of healthcare operating and investing experience. Most recently, Lynne worked for 8 years at Abbott Vascular and Guidant in multiple roles and worked on the launch of over 10 interventional cardiology and cardiac surgery product families. Most recently, Lynne led the global launch of Absorb, the world’s first bioresorbable vascular scaffold, recognized by Wall Street Journal as Medical Device Technology Innovation of the Year and Popular Mechanics. Lynne was responsible for building the global commercial strategy and therapy development as well as playing a key role in the clinical, reimbursement, operational strategy for the therapy.

Skip Fleshman has been at Asset Management Ventures (“AMV”) since 2002 and is actively investing in companies that focus on digital health, mobile and data analytics.

Skip was an officer in the United States Air Force where he first served as a fighter pilot flying the F-16. He flew 37 combat missions during Operation Desert Storm and also served as the wing expert in electronic combat systems and programs. He then founded and served as COO of BGI which develops software for flight simulators and training solutions for the aviation industry.

Skip is an advisor to Stanford’s StartX, Rock Health and Boston Children’s Hospital. He enjoys outdoor activities, fine wine, flying and attending the World Cup (five in a row now).